comparemela.com

Latest Breaking News On - Oxide nasal spray - Page 2 : comparemela.com

First nasal spray for treating adult COVID-19 patients launched in India

Glenmark received manufacturing and marketing approval from DCGI for Nitric Oxide Nasal Spray

New delhiRobert crockartMonika tandonSrikanth krishnamurthyUtah state university united statesGlenmark pharmaceuticals ltdNitric oxide nasal sprayDrugs controller generalOxide nasal sprayNitric oxide nasalChief commercial officer robert crockartClinical developmentGlenmark pharmaceuticalsPrincipal investigatorsAbispray nasal sprayAbispray covid nasal spray

Glenmark launches nitric oxide nasal spray for treatment of COVID-19 patients in India

In a major development in the COVID-19 medicine field, Glenmark Pharmaceuticals on Wednesday launched its Nitric Oxide Nasal Spray under the brand name FabiSpray in India.

Robert crockartSanotize research development corpMinistry of healthGlenmark pharmaceuticals limitedGlenmark pharmaceuticals onGlenmark pharmaceuticals ltdGlenmark pharmaceuticalsNitric oxide nasal sprayPharmaceuticals limitedDrugs controller generalOxide nasal sprayNitric oxide nasalChief commercial officer robert crockartFamily welfare

Nitric Oxide nasal spray in India for the treatment of adult patients with Covid-19

Glenmark earlier received manufacturing and marketing approval from the Drugs Controller General of India

Hong kongUnited kingdomRepublic ofEast timorSri lankaRobert crockartMonika tandonSrikanth krishnamurthyUtah state university united statesStrategic partnershipSanotize research development corpGlenmark pharmaceuticals limitedGlenmark pharmaceuticals ltdCompany rankingsClinical developmentDevelopment corp

Covid-19: First nasal spray for treating adult patients launched in India

The drug reduces a viral load of 94 per cent in 24 hours and 99 per cent in 48 hours, said a drug authority

Robert crockartMonika tandonGlenmark pharmaceuticals ltdNitric oxide nasal sprayDrugs controller generalOxide nasal sprayNitric oxide nasalChief commercial officer robert crockartClinical developmentGlenmark pharmaceuticals

First nasal spray for treating adult COVID-19 patients launched in India

Mumbai based innovation-driven global pharma company Glenmark has launched Nitric Oxide Nasal Spray (FabiSpray) in India, in partnership with SaNOtize, for trea

Robert crockartMonika tandonSrikanth krishnamurthyUtah state university united statesGlenmark pharmaceuticals ltdShalini bhardwajnew delhiNitric oxide nasal sprayDrugs controller generalOxide nasal sprayNitric oxide nasalChief commercial officer robert crockartClinical developmentGlenmark pharmaceuticalsPrincipal investigatorsBreaking health newsHe covid

vimarsana © 2020. All Rights Reserved.